Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

All too easy: Obama signs US FDA user fee bill without fanfare

This article was originally published in Scrip

Executive Summary

Perhaps it was a move by the White House to avoid any uncomfortable photos of President Barack Obama surrounded by drug industry insiders after the rumpus raised in recent weeks over email exchanges during the 2009 health care reform negotiations, but the legislation reauthorizing the Prescription Drug User Fee Act (PDUFA) quietly slid across the president’s desk on 9 July, with no fanfare (scripintelligence, 11 June 2012, 1 June 2012).

Latest Headlines
See All
UsernamePublicRestriction

Register

SC018044

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel